NCCN Guidelines® Insights - Non–Small Cell Lung Cancer, Version 5.2018

The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.

Stage III NSCLC: Practical Application of Immune Checkpoint Inhibition After Chemoradiotherapy

The goal of this activity is to improve participants’ knowledge of and competence in applying immune checkpoint inhibitors in the treatment of patients with stage III NSCLC.

 

Jointly provided by NCCN and Clinical Care Options, LLC.

Stage III NSCLC: Practical Application of Immune Checkpoint Inhibition After Chemoradiotherapy

The goal of this activity is to improve participants’ knowledge of and competence in applying immune checkpoint inhibitors in the treatment of patients with stage III NSCLC.

Stage III NSCLC: Practical Application of Immune Checkpoint Inhibition After Chemoradiotherapy

The goal of this activity is to improve participants’ knowledge of and competence in applying immune checkpoint inhibitors in the treatment of patients with stage III NSCLC.

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer: Early Stage Disease

Join Bill Loo, MD, PhD and Natalie Lui, MD from Stanford Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to early stage lung cancer.

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer: Advanced Disease

Join James Stevenson, MD, and Sanjay Mukhopadhyay, MD, from Cleveland Clinic Taussig Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to advanced lung cancer.

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer: Early Stage Disease

Join Bill Loo, MD, PhD and Natalie Lui, MD from Stanford Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to early stage lung cancer.

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer: Advanced Disease

Join James Stevenson, MD, and Sanjay Mukhopadhyay, MD, from Cleveland Clinic Taussig Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to advanced lung cancer.

Recorded Presentation from the 2017 NCCN Case Manager and Medical Director Program: Updates in the Diagnosis and Treatment of Lung Cancer

Join Gregory A.

Recorded Presentation from the NCCN 2017 Congress Webinar Series™: Lung Cancer - New Strategies to Improve the Accuracy of Lung Cancer Screening

The goal of this educational program is to ensure that members of a multidisciplinary team, including physicians, nurses, pharmacists, and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practices and healthcare settings for

Pages

Subscribe to RSS - Lung Cancers